Funding for this research was provided by:
Nabel President's Fund
Article History
Received: 27 October 2020
Accepted: 14 April 2021
First Online: 5 May 2021
Declarations
:
: None of the study’s commercial vendors participated in design, analysis, interpretation, preparation, review, or approval. Dr. Levine is the recipient of funding from Biofourmis for an investigator-initiated study of machine learning warning scores for acutely ill patients, both traditionally and home hospitalized. Dr. Schnipper was the recipient of funding from Mallinckrodt Pharmaceuticals for an investigator-initiated study of opioid related adverse drug events in post-operative hospitalized patients. Otherwise, the authors declare that they do not have a conflict of interest.
Free to read: This content has been made available to all.